» Articles » PMID: 31510822

Pitfalls of Delaying the Diagnosis of Hereditary Haemorrhagic Telangiectasia

Overview
Journal J Int Med Res
Publisher Sage Publications
Specialty General Medicine
Date 2019 Sep 13
PMID 31510822
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Hereditary haemorrhagic telangiectasia (HHT; Osler-Weber-Rendu disease) is an autosomal dominant vascular disease characterized by nosebleeds, mucocutaneous telangiectases, visceral arteriovenous malformations (AVM) and a first-degree relative with HHT. Diagnosis is definite if three or four criteria are present. This case report describes a 19-year-old male with incidentally detected polycythaemia and an associated soft-tissue opacity over the left lower lobe on his frontal chest radiogram. He had experienced dyspnoea on exertion since infancy and clubbing at physical examination. Polycythaemia vera, chronic obstructive pulmonary disease, sleep apnoea and cyanotic congenital heart disease were excluded. Chest computed tomography (CT) was initially refused by the patient, but 3 years later he presented with severe epistaxis. Considering the unvarying soft tissue mass and erythrocytosis, an HHT-associated pulmonary AVM (PAVM) was eventually confirmed by chest CT. A pathogenic family-specific mutation was detected in the patient. The large PAVM was successfully treated using AMPLATZER™ vascular plug embolization. A combination of the multisystemic nature of his symptoms, the age-related penetrance of HHT symptoms and insufficient patient compliance delayed the diagnosis of HHT in this current case.

Citing Articles

Current Status of Clinical and Genetic Screening of Hereditary Hemorrhagic Telangiectasia Families in Hungary.

Major T, Bereczky Z, Gindele R, Balogh G, Racz B, Bora L J Clin Med. 2021; 10(17).

PMID: 34501220 PMC: 8432115. DOI: 10.3390/jcm10173774.


Resolving Differential Diagnostic Problems in von Willebrand Disease, in Fibrinogen Disorders, in Prekallikrein Deficiency and in Hereditary Hemorrhagic Telangiectasia by Next-Generation Sequencing.

Gindele R, Kerenyi A, Kallai J, Pfliegler G, Schlammadinger A, Szegedi I Life (Basel). 2021; 11(3).

PMID: 33807613 PMC: 7999415. DOI: 10.3390/life11030202.

References
1.
Shovlin C, Guttmacher A, Buscarini E, Faughnan M, Hyland R, Westermann C . Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet. 2000; 91(1):66-7. DOI: 10.1002/(sici)1096-8628(20000306)91:1<66::aid-ajmg12>3.0.co;2-p. View

2.
Gill S, Roddie M, Shovlin C, Jackson J . Pulmonary arteriovenous malformations and their mimics. Clin Radiol. 2014; 70(1):96-110. DOI: 10.1016/j.crad.2014.09.003. View

3.
Faughnan M, Palda V, Garcia-Tsao G, Geisthoff U, McDonald J, Proctor D . International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet. 2009; 48(2):73-87. DOI: 10.1136/jmg.2009.069013. View

4.
Major T, Gindele R, Szabo Z, Kis Z, Bora L, Joni N . The Stratified Population Screening of Hereditary Hemorrhagic Telangiectasia. Pathol Oncol Res. 2019; 26(4):2783-2788. DOI: 10.1007/s12253-019-00602-7. View

5.
Rauh N, Gurley J, Saha S . Contemporary Management of Pulmonary Arteriovenous Malformations. Int J Angiol. 2017; 26(4):205-211. PMC: 5685787. DOI: 10.1055/s-0037-1607033. View